Opportunity Information: Apply for RFA TW 21 003
The Fogarty Global Trauma and Injury Research Training Program (D43 Clinical Trial Optional) is a National Institutes of Health (NIH) discretionary grant opportunity (Funding Opportunity Number RFA TW 21 003) designed to build sustainable trauma and injury research capacity in low- and middle-income countries (LMICs). Its central aim is to strengthen academic institutions in LMIC settings by supporting structured research training programs that prepare individuals and institutions to conduct high-quality studies on trauma and injury prevention, care, and outcomes. The "D43" mechanism signals that this is primarily a research training program award rather than a traditional research project grant, with an emphasis on developing the workforce, mentorship, and institutional systems needed for long-term research productivity. The "Clinical Trial Optional" designation means applicants may propose training that includes clinical trial-related research components if appropriate, but a clinical trial is not required.
The opportunity falls under the NIH health funding activity category and is associated with CFDA numbers 93.853 and 93.989, indicating its placement within NIH-supported global health and research training portfolios. Eligible applicant organizations include public and state-controlled institutions of higher education and private institutions of higher education, with additional eligibility explicitly extending to certain minority-serving and tribal institutions. These include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), and other qualifying entities. This eligibility language signals an intent to broaden participation and encourage partnerships that can support equitable global research training collaborations.
Administratively, the announcement was created on February 17, 2021, with an original application closing date of April 16, 2021. While the source data does not provide an award ceiling or the expected number of awards, the stated purpose makes clear that funding is intended to support comprehensive training activities that enhance LMIC institutional capacity in trauma and injury research. In practical terms, the program is aimed at helping LMIC academic institutions cultivate trained investigators, develop mentorship and research management structures, and expand the ability to design and conduct rigorous studies that address local and regional trauma and injury burdens.Apply for RFA TW 21 003
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Fogarty Global Trauma and Injury Research Training Program (D43 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853, 93.989.
- This funding opportunity was created on 2021-02-17.
- Applicants must submit their applications by 2021-04-16. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Public and State controlled institutions of higher education, Private institutions of higher education, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
Previous opportunity: U.S. Department of Justice Coordinated Tribal Assistance Solicitation Fiscal year 2021 Competitive Grant Announcement
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA TW 21 003
Applicants also applied for:
Applicants who have applied for this opportunity (RFA TW 21 003) also looked into and applied for these:
| Funding Opportunity |
|---|
| Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) Apply for PAR 21 120 Funding Number: PAR 21 120 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34 - Clinical Trial Not Allowed) Apply for PAR 21 146 Funding Number: PAR 21 146 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 21 007 Funding Number: RFA AI 21 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Facility and Building System Upgrades Support for the Regional Biocontainment Laboratories (G20 Clinical Trial Not Allowed) Apply for RFA AI 21 022 Funding Number: RFA AI 21 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Clinical Centers (Collaborative UG3/UH3 Clinical Trial Required) Apply for RFA HL 22 007 Funding Number: RFA HL 22 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maximizing Access to Research Careers (T34 - Clinical Trial Not Allowed) Apply for PAR 21 147 Funding Number: PAR 21 147 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mental Health Research Awards for Investigators Early in their Career in Low and Middle-Income Countries (R01 Clinical Trial Optional) Apply for RFA MH 21 120 Funding Number: RFA MH 21 120 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NINDS Institutional Research Training Program (T32 - Clinical Trial Not Allowed) Apply for PAR 21 149 Funding Number: PAR 21 149 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Lung Transplant Consortium - Clinical Centers (U01 - Clinical Trial Not Allowed) Apply for RFA HL 22 002 Funding Number: RFA HL 22 002 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Lung Transplant Consortium - Data Coordinating Center (U24 - Clinical Trial Not Allowed) Apply for RFA HL 22 003 Funding Number: RFA HL 22 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| The Midlife in the United States Study (U19 Clinical Trial Not Allowed) Apply for PAR 21 156 Funding Number: PAR 21 156 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| The Midlife in the United States Study - Cognitive and Neurocognitive Precursors of AD/ADRD (U01 Clinical Trial Not Allowed) Apply for PAR 21 157 Funding Number: PAR 21 157 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Triadic Interactions in Clinical Encounters Involving People with Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD), Clinicians, and Care Partners (R01 Clinical Trial Optional) Apply for RFA AG 22 020 Funding Number: RFA AG 22 020 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required) Apply for PAR 21 133 Funding Number: PAR 21 133 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) Apply for PAR 21 135 Funding Number: PAR 21 135 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required) Apply for PAR 21 134 Funding Number: PAR 21 134 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 Clinical Trial Required) Apply for PAR 21 131 Funding Number: PAR 21 131 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) Apply for PAR 21 132 Funding Number: PAR 21 132 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AD/ADRD Clinical Trials Short Course (R25 Independent Clinical Trial Not Allowed) Apply for PAR 21 141 Funding Number: PAR 21 141 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) Apply for PAR 21 160 Funding Number: PAR 21 160 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA TW 21 003", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.